Wednesday
For nearly two decades Linda Van Eldik, Ph.D., director of UK’s Sanders-Brown Center on Aging, has worked toward a goal: developing a drug that could help protect the brain from the damaging inflammation associated with Alzheimer’s disease. Now, a new grant from the National Institute on Aging will help her and a team of collaborators take the next step — testing the drug candidate in people with mild cognitive impairment or early Alzheimer’s disease.